Devin W. Steenkamp, MBChB
Endocrinologist
Director of the Clinical Diabetes Program
Boston Medical Center
Assistant Professor, Medicine, Endocrinology, Diabetes, Nutrition & Weight Management, Boston University Chobanian & Avedisian School of Medicine
Devin W. Steenkamp, MBChB, is a endocrinologist at Boston Medical Center (BMC). Dr. Steenkamp is also Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition and an associate professor of medicine at Boston University Chobanian & Avedisian School of Medicine.
He has particular interest in type 1 diabetes and atypical diabetes phenotypes such as monogenic diabetes. His clinical practice and research interests are focused on the application of diabetes technologies in care. Dr. Steenkamp is board certified in Internal Medicine and Endocrinology, Diabetes and Metabolism.
- Residency
Internal Medicine, Icahn School of Medicine at Mount Sinai/Morningside/West, 2008-2011 - Fellowship
Endocrinology, Diabetes, and Metabolism, Boston University Medical Center, 2011-2013 - Board Certifications
American Board of Internal Medicine: Internal Medicine, Endocrinology, Diabetes and Metabolism
Devin Steenkamp is Associate Professor of Medicine in the Section of Endocrinology, Diabetes, Nutrition and Weight Management at Chobanian and Avedisian School of Medicine, Boston, MA. Dr. Steenkamp is an adult endocrinologist with a particular interest in type 1 diabetes, atypical diabetes phenotypes and diabetes technology. He is the Director of the Clinical Diabetes Program in the Section of Endocrinology, Diabetes and Nutrition at Boston Medical Center/Chobanian and Avedisian School of Medicine.
He established the diabetes technology program, with a particular focus on utilizing modern technologies to improve the care and outcomes for underserved adults living with diabetes.
In his clinical leadership role, he is responsible for leading a team of multidisciplinary clinicians with specific expertise in implementing advanced diabetes technologies into care and has overseen the development of various innovative clinical programs. Dr. Steenkamp has also been a leader integral to the advancement of the diabetes clinical research program and has been an investigator on multiple multi-center clinical trials and translational projects, sponsored by the NIH, various foundations and industry sponsors.